Back to results
US 8,410,159 B2Granted
Imidazole compounds having pharmaceutical activity towards the sigma receptor
AssigneeLaboratories Del Dr. Esteve, S.A.
InventorsRosa Cuberes-Altisent, Joerg Holenz
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds of formula (I), methods for their preparation, medicaments comprising these compounds as well their use in the manufacture of a medicament for the treatment of humans and animals.
Claims5
A method for the treatment of neuropathic pain, said method comprising administering to a subject in need thereof a therapeutically effective amount of a compound of formula I
- wherein
- R1 represents H, F, Cl, Br, I, OH, CF3, methyl or ethyl;
- R2 represents H, F, Cl, Br, I, OH, CF3, methyl or ethyl;
- R3 represents an optionally substituted tert-butyl;
- an unsubstituted, mono- or disubstituted cyclohexyl;
- an unsubstituted, mono- or di-substituted phenyl or an unsubstituted, mono- or di-substituted naphthyl group with substituents independently selected from the group consisting of F, Cl, Br, I, NH2, SH, OH, SO2, and CF3;
- R4 represents H;
- R5 and R6, identical or different, represent a hydrogen atom;
- an unbranched or branched, optionally substituted C1-6 alkyl group with substituents independently selected from the group consisting of F, Cl, Br, I, NH2, SH, OH, SO2, and CF3;
- a saturated cycloalkyl group which is optionally substituted with substituents independently selected from the group consisting of F, Cl, Br, I, NH2, SH, OH, SO2, and CF3;
- a branched or unbranched alkyl-aryl group which is optionally substituted with substituents independently selected from the group consisting of F, Cl, Br, I, NH2, SH, OH, SO2, and CF3;
- or
- form together with the bridging nitrogen atom a piperidine;
- morpholine;
- pyrrolidine;
- azepane or piperazine group which is optionally substituted with substituents independently selected from the group consisting of halogen, NH2, SH, OH, SO2, optionally substituted C1-6-Alkyl, optionally substituted O—C1-6-Alkyl, optionally substituted C(O)—C1-6-Alkyl, and optionally substituted C3-6-Cycloalkyl;
- preferably with substituents independently selected from the group consisting of methyl, ethyl, methoxy, ethoxy, C(O)—CH3, F, Cl, Br, I, NH2, SH, OH, SO2, CF3, and cyclohexyl;
- most preferably with substituents independently selected from the group consisting of C(O)—CH3, methyl, and cyclohexyl;
- X represents a C═O— group;
- Y represents a nitrogen atom, a sulfur atom, or an SO2 group;
- m is selected from 0 and 1;
- n is selected from 0 and 1;
- p is selected from 1, 2, 3, and 4;
- optionally in form of one of the stereoisomers, preferably enantiomers or diastereomers, a racemate or in form of a mixture of at least two of the stereoisomers, preferably enantiomers and/or diastereomers, in any mixing ratio, or a corresponding salt thereof.
21 more elements
Dependencies are inferred from the claim text.